封面
市場調查報告書
商品編碼
1836311

經導管栓塞及封堵裝置市場(依產品、國家及地區)-2025 年至 2032 年全球產業分析、市場規模、市場佔有率及預測

Transcatheter Embolization and Occlusion Devices Market, By Product, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年經導管栓塞和封堵裝置市場規模價值 54.932 億美元,2025 年至 2032 年的複合年成長率為 7.80%。

經導管栓塞和封堵裝置能夠利用導管將合成栓子經由特定身體部位插入或送入體內。經導管栓塞是一種微創技術,用於介入放射學,以阻斷流向癌性腫瘤的血流。為了探索多種靶向腫瘤的策略,合成材料偶爾會用於包裹化療藥物,以同時阻斷血液供應並產生細胞毒性。

經導管栓塞及封堵裝置市場-市場動態

對微創技術的需求不斷增加,推動了市場的成長。

微創技術日益成長的需求預計將在不久的將來推動經導管栓塞和封鎖裝置市場的成長。微創手術利用小切口或自然體孔進入並治療內部結構、器官或組織,從而減少對患者身體的創傷。經導管栓塞和封堵裝置在這些技術中發揮重要作用,具有許多優勢,例如創傷小、恢復時間短、治療針對性強、疼痛輕、併發症風險低以及可進行門診手術。例如,美國一家專門從事微創醫療產品的科技公司 Intuitive Surgical Inc. 報告稱,2022 年使用達文西手術系統進行的手術約有 1,875,000 例,比 2021 年的約 1,594,000 例成長 18%。因此,對微創技術日益成長的需求是經導管栓塞和封堵裝置市場的主要驅動力。

經導管栓塞及封堵裝置市場-細分分析:

全球經導管栓塞和閉塞裝置市場根據產品和地區進行細分。

市場由兩大產品類別構成:彈簧圈和非彈簧圈。非彈簧圈產品憑藉其在各種臨床應用中的多功能性和有效性,將在2025年佔據市場主導地位,並佔據最高收入佔有率。非彈簧圈設備,例如液體栓塞劑和顆粒栓塞產品,可提供精確且可控制的栓塞,是治療複雜血管疾病的理想選擇。它們能夠輕鬆應對複雜的解剖結構,並以最少的併發症提供卓越的治療效果,贏得了介入放射科醫生和外科醫生的高度讚譽。這種日益成長的偏好也鞏固了該領域的市場主導地位。

經導管栓塞及封堵裝置市場-地理洞察

2025年,北美經導管栓塞和封堵裝置市場將佔據全球市場主導地位。這得益於介入放射學 (IR) 手術的日益普及。子宮肌瘤栓塞術 (UFE) 是一種微創的 IR 手術,作為有症狀子宮肌瘤的治療選擇,正日益受到青睞。這種非手術方法可以加快患者康復,並減少子宮切除術的需求。患者對微創治療的需求不斷成長,加上醫療保健提供者的認知度不斷提高,推動了栓塞裝置的使用,並擴大了這些創新解決方案的市場。這些裝置用於治療心房顫動和靜脈曲張。

預計亞太地區經導管栓塞和封堵裝置市場將在2025年至2032年間實現最快成長。該地區癌症發生率的不斷上升推動了對這些裝置的需求。它們為多種癌症提供了有效的治療選擇,包括肝癌和肺癌,而栓塞是腫瘤管理的​​重要組成部分。醫療保健投資的不斷增加,透過擴大先進醫療技術的可近性和改善醫療保健基礎設施,正在推動市場成長。癌症發生率的上升和醫療保健能力的不斷提升,預計將推動整個地區的經導管栓塞和封鎖裝置產業向前發展。

經導管栓塞及封堵裝置市場-競爭格局:

經導管栓塞和封堵裝置市場競爭激烈,雅培、波士頓科學公司、泰爾茂公司、美敦力和DePuy Synthes(強生公司)佔據領先地位。這些公司提供各種創新設備,例如栓塞線圈、血管栓塞和液體栓塞劑,這些設備通常與先進的成像和導管導航系統整合。競爭圍繞著技術創新、小型化以及提高腫瘤、神經病學和周邊血管手術的安全性和有效性。

目錄

第 1 章:經導管栓塞與封堵裝置市場概述

  • 研究範圍
  • 市場估計年限

第2章:執行摘要

  • 市場片段
    • 經導管栓塞及封堵裝置市場(依產品)
    • 經導管栓塞和封堵裝置市場(按國家/地區)
    • 經導管栓塞及封堵裝置市場(按地區)
  • 競爭洞察

第3章:經導管栓塞和封堵裝置的主要市場趨勢

  • 經導管栓塞及封堵裝置市場促進因素
    • 市場促進因素的影響分析
  • 經導管栓塞及封堵裝置市場限制
    • 市場限制的影響分析
  • 經導管栓塞及封堵裝置的市場機會
  • 經導管栓塞及封堵裝置市場未來趨勢

第4章:經導管栓塞及封堵裝置產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章:經導管栓塞與封堵裝置市場:地緣政治緊張局勢升級的影響

  • COVID-19 疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章:經導管栓塞及封堵裝置市場格局

  • 經導管栓塞及封堵裝置市佔率分析(2024年)
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章:經導管栓塞和封堵裝置市場 - 按產品

  • 概述
    • 按產品細分市場佔有率分析
    • 線圈
      • 可推式線圈
      • 可拆卸彈簧圈
    • 非線圈
      • 流量轉向裝置
      • 栓塞顆粒
      • 液態栓塞劑
      • 其他栓塞及封堵裝置
      • 配件

第 8 章:經導管栓塞和封堵裝置市場 - 按地區

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美經導管栓塞和封堵裝置主要製造商
    • 北美市場規模及預測(按國家/地區)
    • 北美市場規模及預測(按產品)
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲經導管栓塞及封堵裝置主要製造商
    • 歐洲市場規模及預測(按國家/地區)
    • 歐洲市場規模及預測(按產品)
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區(APAC)
    • 概述
    • 亞太地區經導管栓塞及封堵裝置主要製造商
    • 亞太地區市場規模及預測(依國家)
    • 亞太地區市場規模及預測(依產品)
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲(LATAM)
    • 概述
    • 拉丁美洲經導管栓塞和封堵裝置主要製造商
    • 拉丁美洲市場規模及預測(按國家/地區)
    • 拉丁美洲市場規模及預測(按產品)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲(MEA)
    • 概述
    • 中東和非洲經導管栓塞和封堵裝置主要製造商
    • MEA 市場規模及預測(依國家/地區)
    • MEA 市場規模及預測(依產品)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第9章:主要供應商分析-經導管栓塞及封堵裝置產業

  • 競爭基準化分析
    • Competitive Dashboard
    • Competitive Positioning
  • 公司簡介
    • Abbott
    • Boston Scientific Corporation
    • Terumo Corporation
    • Medtronic
    • DePuy Synthes (Johnson & Johnson)
    • Stryker
    • Cordis
    • Pfizer Inc.
    • Sirtex SIR-Spheres Pty Ltd.
    • Nordion (Canada) Inc.
    • Others

第 10 章:360 度分析師視角

第 11 章:附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5615

Transcatheter Embolization and Occlusion Devices Market size was valued at US$ 5,493.20 Million in 2024, expanding at a CAGR of 7.80% from 2025 to 2032.

Transcatheter embolization and occlusion devices enable the insertion or passage of a synthetic embolus into the body via a specific body part while utilizing a catheter. Transcatheter embolization is a minimally invasive technique used in interventional radiology to stop blood flow to cancerous tumors. To identify many strategies for targeting tumors, synthetic materials are occasionally used to coat chemotherapeutic medications in order to perform simultaneous acts of blood supply blocking and cytotoxicity.

Transcatheter Embolization and Occlusion Devices Market- Market Dynamics

Increasing demand for minimally invasive techniques fuels market growth.

The growing demand for minimally invasive techniques is expected to drive the growth of the transcatheter embolization and occlusion device market in the near future. Minimally invasive surgeries use small incisions or natural body openings to access and treat internal structures, organs, or tissues, reducing trauma to the patient's body. Transcatheter embolization and occlusion devices play an important role in these techniques, providing numerous benefits such as reduced invasiveness, shorter recovery times, targeted treatment, less pain, lower complication risks, and the possibility of outpatient procedures. For instance, Intuitive Surgical Inc., a US-based technology corporation specializing in minimally invasive medical products, reported that approximately 1,875,000 surgical procedures were performed using da Vinci surgical systems in 2022, up 18% from about 1,594,000 in 2021. As a result, the growing demand for minimally invasive techniques is a major driver in the transcatheter embolization and occlusion devices market.

Transcatheter Embolization and Occlusion Devices Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.80% over the forecast period (2025-2032)

Based on Product segmentation, non-coil was predicted to show maximum market share in the year 2024

On the basis of region, North American was the leading revenue generator in 2024

Transcatheter Embolisation and Occlusion Devices Market- Segmentation Analysis:

The Global Transcatheter Embolisation and Occlusion Devices Market is segmented on the basis of Product and Region.

Two product-based categories comprise the market: Coil and Non-Coil. The non-coil segment will dominate the market with the highest revenue share in 2025, owing to its versatility and effectiveness in a variety of clinical applications. Non-coil devices, such as liquid embolic agents and particle embolization products, provide precise and controlled embolization, which is ideal for treating complex vascular conditions. Their ability to navigate difficult anatomy and provide superior results with minimal complications has earned them high praise among interventional radiologists and surgeons. This growing preference has contributed to the segment's market dominance.

Transcatheter Embolization and Occlusion Devices Market- Geographical Insights

The North American transcatheter embolization and occlusion device market will dominate the global market in 2025. This is due to the increased use of interventional radiology (IR) procedures. Uterine Fibroid Embolization (UFE), a minimally invasive IR procedure, is increasingly popular as a treatment option for symptomatic uterine fibroids. This nonsurgical approach allows for faster recovery and reduces the need for hysterectomy. Rising patient demand for less invasive treatments, combined with increased awareness among healthcare providers, is driving up the use of embolization devices and expanding the market for these innovative solutions. These devices are used to treat atrial fibrillation and varicose veins.

The Asia Pacific transcatheter embolization and occlusion device market is expected to grow the fastest between 2025 and 2032. The growing prevalence of cancer in the region is driving up demand for these devices. They provide effective treatment options for a variety of cancers, including liver and lung cancer, where embolization is an important part of tumor management. Rising healthcare investments are fueling market growth by increasing access to advanced medical technologies and improving healthcare infrastructure. This combination of rising cancer rates and expanding healthcare capabilities is expected to propel the transcatheter embolization and occlusion devices industry forward across the region.

Transcatheter Embolization and Occlusion Devices Market- Competitive Landscape:

The Transcatheter Embolization and Occlusion Devices Market is highly competitive, with Abbott, Boston Scientific Corporation, Terumo Corporation, Medtronic, and DePuy Synthes (Johnson & Johnson) leading the way. These companies provide a diverse range of innovative devices, such as embolization coils, vascular plugs, and liquid embolic agents, which are frequently integrated with advanced imaging and catheter navigation systems. The competition revolves around technological innovation, miniaturization, and increased safety and efficacy for oncology, neurology, and peripheral vascular procedures.

Recent Developments:

In January 2025, Stryker has agreed to acquire Inari Medical for USD 4.9 billion, expanding its presence in venous thromboembolism care.

In July 2025, Teleflex acquired BIOTRONIK's vascular intervention business for EUR 760 million, expanding its portfolio to include drug-coated balloons and the Freesolve resorbable scaffold.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott
  • Boston Scientific Corporation
  • Terumo Corporation
  • Medtronic
  • DePuy Synthes (Johnson & Johnson)
  • Stryker
  • Cordis
  • Pfizer Inc.
  • Sirtex SIR-Spheres Pty Ltd.
  • Nordion (Canada) Inc.
  • Others

GLOBAL TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Coil
  • Pushable Coils
  • Detachable Coils
  • Non Coil
  • Flow Diverting Devices
  • Embolization Particles
  • Liquid Embolics
  • Other Embolization and Occlusion Devices
  • Accessories

GLOBAL TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Transcatheter Embolization And Occlusion Devices Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Transcatheter Embolization And Occlusion Devices Market Snippet by Product
    • 2.1.2. Transcatheter Embolization And Occlusion Devices Market Snippet by Country
    • 2.1.3. Transcatheter Embolization And Occlusion Devices Market Snippet by Region
  • 2.2. Competitive Insights

3. Transcatheter Embolization And Occlusion Devices Key Market Trends

  • 3.1. Transcatheter Embolization And Occlusion Devices Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Transcatheter Embolization And Occlusion Devices Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Transcatheter Embolization And Occlusion Devices Market Opportunities
  • 3.4. Transcatheter Embolization And Occlusion Devices Market Future Trends

4. Transcatheter Embolization And Occlusion Devices Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Transcatheter Embolization And Occlusion Devices Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Transcatheter Embolization And Occlusion Devices Market Landscape

  • 6.1. Transcatheter Embolization And Occlusion Devices Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Transcatheter Embolization And Occlusion Devices Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Coil
      • 7.1.2.1. Pushable Coils
      • 7.1.2.2. Detachable Coils
    • 7.1.3. Non Coil
      • 7.1.3.1. Flow Diverting Devices
      • 7.1.3.2. Embolization Particles
      • 7.1.3.3. Liquid Embolics
      • 7.1.3.4. Other Embolization and Occlusion Devices
      • 7.1.3.5. Accessories

8. Transcatheter Embolization And Occlusion Devices Market- By Geography

  • 8.1. Introduction
    • 8.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 8.2. North America
    • 8.2.1. Overview
    • 8.2.2. Transcatheter Embolization And Occlusion Devices Key Manufacturers in North America
    • 8.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 8.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.2.5. U.S.
      • 8.2.5.1. Overview
      • 8.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.2.5.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.2.6. Canada
      • 8.2.6.1. Overview
      • 8.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.2.6.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  • 8.3. Europe
    • 8.3.1. Overview
    • 8.3.2. Transcatheter Embolization And Occlusion Devices Key Manufacturers in Europe
    • 8.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 8.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.3.5. Germany
      • 8.3.5.1. Overview
      • 8.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.5.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.3.6. UK
      • 8.3.6.1. Overview
      • 8.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.6.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.3.7. France
      • 8.3.7.1. Overview
      • 8.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.7.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.3.8. Italy
      • 8.3.8.1. Overview
      • 8.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.8.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.3.9. Spain
      • 8.3.9.1. Overview
      • 8.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.9.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.3.10. The Netherlands
      • 8.3.10.1. Overview
      • 8.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.10.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.3.11. Sweden
      • 8.3.11.1. Overview
      • 8.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.11.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.3.12. Russia
      • 8.3.12.1. Overview
      • 8.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.12.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.3.13. Poland
      • 8.3.13.1. Overview
      • 8.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.13.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.3.14. Rest of Europe
      • 8.3.14.1. Overview
      • 8.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.14.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  • 8.4. Asia Pacific (APAC)
    • 8.4.1. Overview
    • 8.4.2. Transcatheter Embolization And Occlusion Devices Key Manufacturers in Asia Pacific
    • 8.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 8.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.4.5. China
      • 8.4.5.1. Overview
      • 8.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.5.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.4.6. India
      • 8.4.6.1. Overview
      • 8.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.6.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.4.7. Japan
      • 8.4.7.1. Overview
      • 8.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.7.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.4.8. South Korea
      • 8.4.8.1. Overview
      • 8.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.8.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.4.9. Australia
      • 8.4.9.1. Overview
      • 8.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.9.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.4.10. Indonesia
      • 8.4.10.1. Overview
      • 8.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.10.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.4.11. Thailand
      • 8.4.11.1. Overview
      • 8.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.11.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.4.12. Philippines
      • 8.4.12.1. Overview
      • 8.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.12.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.4.13. Rest of APAC
      • 8.4.13.1. Overview
      • 8.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.13.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  • 8.5. Latin America (LATAM)
    • 8.5.1. Overview
    • 8.5.2. Transcatheter Embolization And Occlusion Devices Key Manufacturers in Latin America
    • 8.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 8.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.5.5. Brazil
      • 8.5.5.1. Overview
      • 8.5.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.5.5.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.5.6. Mexico
      • 8.5.6.1. Overview
      • 8.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.5.6.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.5.7. Argentina
      • 8.5.7.1. Overview
      • 8.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.5.7.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.5.8. Colombia
      • 8.5.8.1. Overview
      • 8.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.5.8.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.5.9. Rest of LATAM
      • 8.5.9.1. Overview
      • 8.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.5.9.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  • 8.6. Middle East and Africa (MEA)
    • 8.6.1. Overview
    • 8.6.2. Transcatheter Embolization And Occlusion Devices Key Manufacturers in Middle East and Africa
    • 8.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 8.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.6.5. Saudi Arabia
      • 8.6.5.1. Overview
      • 8.6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.6.5.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.6.6. UAE
      • 8.6.6.1. Overview
      • 8.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.6.6.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.6.7. Israel
      • 8.6.7.1. Overview
      • 8.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.6.7.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.6.8. Turkey
      • 8.6.8.1. Overview
      • 8.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.6.8.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.6.9. Algeria
      • 8.6.9.1. Overview
      • 8.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.6.9.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.6.10. Egypt
      • 8.6.10.1. Overview
      • 8.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.6.10.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.6.11. Rest of MEA
      • 8.6.11.1. Overview
      • 8.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.6.11.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)

9. Key Vendor Analysis- Transcatheter Embolization And Occlusion Devices Industry

  • 9.1. Competitive Benchmarking
    • 9.1.1. Competitive Dashboard
    • 9.1.2. Competitive Positioning
  • 9.2. Company Profiles
    • 9.2.1. Abbott
    • 9.2.2. Boston Scientific Corporation
    • 9.2.3. Terumo Corporation
    • 9.2.4. Medtronic
    • 9.2.5. DePuy Synthes (Johnson & Johnson)
    • 9.2.6. Stryker
    • 9.2.7. Cordis
    • 9.2.8. Pfizer Inc.
    • 9.2.9. Sirtex SIR-Spheres Pty Ltd.
    • 9.2.10. Nordion (Canada) Inc.
    • 9.2.11. Others

10. 360 Degree AnalystView

11. Appendix

  • 11.1. Research Methodology
  • 11.2. References
  • 11.3. Abbreviations
  • 11.4. Disclaimer
  • 11.5. Contact Us